Generative AI In Clinical Trials Market Share

Statistics for the 2023 & 2024 Generative AI In Clinical Trials market share, created by Mordor Intelligence™ Industry Reports. Generative AI In Clinical Trials share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Health Services Research Generative AI In Clinical Trials Market Market Share

Market Share of Generative AI In Clinical Trials Industry

The generative AI in clinical trials market is typically fragmented owing to the presence of a few major technology companies and specialized startups. Several key players are applying AI to drug discovery and clinical trials. Significant investments and strategic partnerships between AI firms and pharmaceutical companies also drive market concentration. Some of the players are leveraging advanced technologies for drug development and clinical trials. Some of the key players in the market are IBM, Tempus, Microsoft Corporation, H1, NVIDIA, and Exscientia.

Generative AI In Clinical Trials Market Leaders

  1. IBM

  2. Tempus

  3. Exscientia

  4. NVIDA

  5. H1

*Disclaimer: Major Players sorted in no particular order

Generative AI In Clinical Trials Market Concentration

Generative AI In Clinical Trials Market Report Snapshots

Generative Ai In Clinical Trials Market Size & Share Analysis - Growth, Trends, and Forecasts (2024 - 2029)